Schedule 13D ownership disclosure

MATINAS BIOPHARMA HLDGS INC

Common Stock · CUSIP: 576810303

Event date: 2025-02-13

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Chaim Herzog

    Shares: 183,639.00 · Class: 3.61%

  • 111 Equity Group LLCReported CIK 0002024448

    Shares: 183,639.00 · Class: 3.61%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001398344-25-003088
Form type
SCHEDULE 13D/A
Filer
111 Equity Group
CIK
CIK 2024448
Filed
Feb 19, 2025
Reporting period
Feb 13, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub